Metastatic Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)
Active, not recruiting
  • Metastatic Cancer
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
  • Melanoma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-04-07
    Apr 7, 2022
    E
    A Study of LY3023414 in Participants With Advanced Cancer - 2022
    Completed
    • Advanced Cancer
    • +5 more
    • Los Angeles, California
    • +7 more
    2022-04-07
    Apr 7, 2022
    B
    A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
    Recruiting
    • Malignant Neoplasms
    • Metastatic Cancer
    • Shanghai, Shanghai, China
    • +4 more
    2022-04-05
    Apr 5, 2022
    M
    A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
    Recruiting
    • Metastatic Cancer
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    2022-03-31
    Mar 31, 2022
    M
    Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)
    Active, not recruiting
    • Advanced Cancer
    • +4 more
    • Saint Louis, Missouri
    • +3 more
    2022-04-04
    Apr 4, 2022
    M
    Predicting Disease Progression and/or Recurrence in Cancer
    Recruiting
    • Patient Reported Outcome Measures
    • +7 more
    • Observational Cohort
    • Boston, Massachusetts
      Massachusetts General Hospital
    2022-04-04
    Apr 4, 2022
    L
    ARREST - A Phase I Study of SABR for Poly-metastatic Disease
    Recruiting
    • Metastatic Cancer
    • Stereotactic ablative radiotherapy - Level 1
    • +4 more
    • London, Ontario, Canada
      London Health Sciences Centre - London Regional Cancer Program
    2022-04-04
    Apr 4, 2022
    U
    Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
    Not yet recruiting
    • Metastatic Cancer
    • +7 more
    • Standard of Care Chemotherapy
    • +7 more
    • (no location specified)
    2022-04-01
    Apr 1, 2022
    C
    (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
    Recruiting
    • Advanced Gastrointestinal Stromal Tumors
    • Metastatic Cancer
    • CGT9486 plus sunitinib
    • +2 more
    • Duarte, California
    • +6 more
    2022-03-31
    Mar 31, 2022
    T
    Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer
    Active, not recruiting
    • Solid Tumor
    • Metastatic Cancer
    • Birmingham, Alabama
    • +3 more
    2022-03-31
    Mar 31, 2022
    T
    COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study
    Not yet recruiting
    • Breast Cancer Invasive
    • +2 more
    • Surgery
    • +2 more
    • Amsterdam, Netherlands
      Antoni van Leeuwenhoek
    2022-03-21
    Mar 21, 2022
    P
    Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours
    Recruiting
    • Metastatic Cancer
    • Epithelial Tumor
    • NG-641 in combination with Nivolumab
    • Santa Monica, California
    • +2 more
    2022-03-16
    Mar 16, 2022
    F
    FS120 First in Human Study in Patients With Advanced Malignancies
    Recruiting
    • Advanced Cancer
    • Metastatic Cancer
    • New Haven, Connecticut
    • +7 more
    2022-03-29
    Mar 29, 2022
    F
    FS222 First in Human Study in Patients With Advanced Malignancies
    Recruiting
    • Advanced Cancer
    • Metastatic Cancer
    • Pamplona, Navarra, Spain
    • +5 more
    2022-03-29
    Mar 29, 2022
    G
    GEN2 Directed Cancer Immunotherapy Trial
    Recruiting
    • Hepatocellular Carcinoma
    • Metastatic Cancer
    • GEN2 (HSV-Thymidine Kinase-m2 and hGM-CSF Genes)
    • Makati City, Philippines
    • +3 more
    2022-03-14
    Mar 14, 2022
    I
    QUILT 3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers
    Active, not recruiting
    • Locally Advanced Solid Tumor
    • +2 more
    • PD-L1 t-haNK
    • El Segundo, California
      Chan Soon-Shiong Institute for Medicine
    2022-03-28
    Mar 28, 2022
    H
    Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
    Recruiting
    • Sarcoma, Synovial
    • +8 more
    • CYCLOPHOSPHAMIDE and FLUDARABIN
    • +3 more
    • Jerusalem, Israel
      Hadassah Medical Organization
    2022-03-15
    Mar 15, 2022
    A
    Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
    Not yet recruiting
    • Advanced Solid Tumor
    • Metastatic Cancer
    • Miranda, New South Wales, Australia
    • +2 more
    2022-03-21
    Mar 21, 2022
    I
    Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
    Active, not recruiting
    Has Results
    • Metastatic Cancer
    • +9 more
    • Mobile, Alabama
    • +19 more
    2022-03-14
    Mar 14, 2022
    A
    A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors
    Recruiting
    • Metastatic Cancer
    • +2 more
    • ASP9801
    • Pembrolizumab
    • Birmingham, Alabama
    • +24 more
    2022-03-20
    Mar 20, 2022
    B
    A Phase 2 Open Label Study of BA3021 in Combination With Nivolumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Not yet recruiting
    • Head and Neck Cancer
    • +4 more
    • Ozuriftamab Vedotin
    • PD-1 inhibitor
    • (no location specified)
    2022-03-08
    Mar 8, 2022
    G
    Study of GNX102 in Patients With Advanced Solid Tumors
    Recruiting
    • Solid Tumor
    • +3 more
    • Los Angeles, California
    • +5 more
    2022-03-07
    Mar 7, 2022
    C
    Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Head and Neck Cancer
    Recruiting
    • Head and Neck Cancer
    • +2 more
    • Standard arm
    • Experimental arm
    • Montréal, Quebec, Canada
      Centre Hospitalier de l'Université de Montréal
    2022-03-06
    Mar 6, 2022
    M
    Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors
    Recruiting
    • Advanced Cancer
    • +5 more
    • Atlanta, Georgia
    • +1 more
    2022-03-04
    Mar 4, 2022